Halil Bagci
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Halil Bagci has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Jean-François Côté
Institut de Recherches Cliniques de Montréal, Montréal, Canada
11 shared publications - Jonathan Boulais
Institut de Recherches Cliniques de Montréal, Montréal, Canada
7 shared publications - Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute, Sinai Health
4 shared publications - Javier Marcelo Di Noia
Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada
3 shared publications - Alexandre Maréchal
Département de biologie, Université de Sherbrooke, Sherbrooke, Canada
2 shared publications - Alexandre Orthwein
Emory University School of Medicine
2 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AID
Activation-induced deaminase (AID) mutates immunoglobulin genes to initiate antibody diversification by class switch recombination and somatic hypermutation but can also target non-immunoglobulin loci with oncogenic consequences. The mechanisms determining gene susceptibility to AID remain unclear. Here, we show that the H3K79 histone methyltransferase DOT1L is proximal to nuclear AID and promotes both class switch recombination and off-target AID activity, including Igh-cMyc translocations in mouse B cells. AID-mutated genes display high DOT1L activity. In the absence of DOT1L, nascent transcription largely increases despite reduced RNA Polymerase II (RNAPII) occupancy. Integrative genomic analyses reveal that DOT1L locally restricts transcription elongation velocity proportionally to H3K79me2/3 levels and extends RNAPII pausing. These transcriptional conditions enhance AID occupancy and thereby its activity. Our findings provide a harmonizing explanation for the bidirectional gene expression changes observed in DOT1L-deficient cells, and link attenuated transcriptional elongation velocity and prolonged RNAPII pausing to productive AID engagement at target loci.
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessDOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AID
Activation-induced deaminase (AID) mutates immunoglobulin genes to initiate antibody diversification by class switch recombination and somatic hypermutation but can also target non-immunoglobulin loci with oncogenic consequences. The mechanisms determining gene susceptibility to AID remain unclear. Here, we show that the H3K79 histone methyltransferase DOT1L is proximal to nuclear AID and promotes both class switch recombination and off-target AID activity, including Igh-cMyc translocations in mouse B cells. AID-mutated genes display high DOT1L activity. In the absence of DOT1L, nascent transcription largely increases despite reduced RNA Polymerase II (RNAPII) occupancy. Integrative genomic analyses reveal that DOT1L locally restricts transcription elongation velocity proportionally to H3K79me2/3 levels and extends RNAPII pausing. These transcriptional conditions enhance AID occupancy and thereby its activity. Our findings provide a harmonizing explanation for the bidirectional gene expression changes observed in DOT1L-deficient cells, and link attenuated transcriptional elongation velocity and prolonged RNAPII pausing to productive AID engagement at target loci.
- Open Access
- 10 October 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202403046
The hGIDGID4E3 ubiquitin ligase complex targets ARHGAP11A to regulate cell migration
The human CTLH/GID (hGID) complex emerged as an important E3 ligase regulating multiple cellular processes, including cell cycle progression and metabolism. However, the range of biological functions controlled by hGID remains unexplored. Here, we used proximity-dependent biotinylation (BioID2) to identify proteins interacting with the hGID complex, among them, substrate candidates that bind GID4 in a pocket-dependent manner. Biochemical and cellular assays revealed that the hGIDGID4E3 ligase binds and ubiquitinates ARHGAP11A, thereby targeting this RhoGAP for proteasomal degradation. Indeed, GID4 depletion or impeding the GID4 substrate binding pocket with the PFI-7 inhibitor stabilizes ARHGAP11A protein amounts, although it carries no functional N-terminal degron. Interestingly, GID4 inactivation impairs cell motility and directed cell movement by increasing ARHGAP11A levels at the cell periphery, where it inactivates RhoA. Together, we identified a wide range of hGIDGID4E3 ligase substrates and uncovered a unique function of the hGIDGID4E3 ligase regulating cell migration by targeting ARHGAP11A.
- 10 October 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202403046
Open AccessThe hGIDGID4E3 ubiquitin ligase complex targets ARHGAP11A to regulate cell migration
The human CTLH/GID (hGID) complex emerged as an important E3 ligase regulating multiple cellular processes, including cell cycle progression and metabolism. However, the range of biological functions controlled by hGID remains unexplored. Here, we used proximity-dependent biotinylation (BioID2) to identify proteins interacting with the hGID complex, among them, substrate candidates that bind GID4 in a pocket-dependent manner. Biochemical and cellular assays revealed that the hGIDGID4E3 ligase binds and ubiquitinates ARHGAP11A, thereby targeting this RhoGAP for proteasomal degradation. Indeed, GID4 depletion or impeding the GID4 substrate binding pocket with the PFI-7 inhibitor stabilizes ARHGAP11A protein amounts, although it carries no functional N-terminal degron. Interestingly, GID4 inactivation impairs cell motility and directed cell movement by increasing ARHGAP11A levels at the cell periphery, where it inactivates RhoA. Together, we identified a wide range of hGIDGID4E3 ligase substrates and uncovered a unique function of the hGIDGID4E3 ligase regulating cell migration by targeting ARHGAP11A.
- Open Access
The hGID GID4 E3 ubiquitin ligase complex targets ARHGAP11A to regulate cell migration
The human CTLH/GID (hGID) complex emerged as an important E3 ligase regulating multiple cellular processes, including cell cycle progression and metabolic activity. However, the range of biological functions controlled by hGID remains unexplored. Here, we show that the hGID substrate receptor GID4 regulates cell growth and migration. Biochemical and cellular assays combined with proximity-dependent biotinylation (BioID2) revealed that the hGID GID4 E3-ligase targets the Rho-GAP ARHGAP11A for degradation. Depletion of GID4 or impeding the GID4 substrate binding pocket impairs motility and directed cell movement, whereas knockdown of ARHGAP11A significantly restores the cell migration defect. We found that GID4 controls cell migration by degrading ARHGAP11A thereby preventing its accumulation at the cell periphery where it inactivates RhoA activity. Together, we identified a unique function for GID4, as well as a wide range of substrate profiles beyond Pro/N-degron motifs, which pave the way for deciphering additional pathways regulated by hGID E3 ligase activity through its GID4 substrate receptor.
Open AccessThe hGID GID4 E3 ubiquitin ligase complex targets ARHGAP11A to regulate cell migration
The human CTLH/GID (hGID) complex emerged as an important E3 ligase regulating multiple cellular processes, including cell cycle progression and metabolic activity. However, the range of biological functions controlled by hGID remains unexplored. Here, we show that the hGID substrate receptor GID4 regulates cell growth and migration. Biochemical and cellular assays combined with proximity-dependent biotinylation (BioID2) revealed that the hGID GID4 E3-ligase targets the Rho-GAP ARHGAP11A for degradation. Depletion of GID4 or impeding the GID4 substrate binding pocket impairs motility and directed cell movement, whereas knockdown of ARHGAP11A significantly restores the cell migration defect. We found that GID4 controls cell migration by degrading ARHGAP11A thereby preventing its accumulation at the cell periphery where it inactivates RhoA activity. Together, we identified a unique function for GID4, as well as a wide range of substrate profiles beyond Pro/N-degron motifs, which pave the way for deciphering additional pathways regulated by hGID E3 ligase activity through its GID4 substrate receptor.
- Open Access
- 21 June 2023
- Published by Springer Nature in Research Square
DOT1L limits RNAPII promoter-proximal pause release thus enabling Activation Induced Deaminase activity genome-wide
Activation induced deaminase (AID) initiates class switch recombination (CSR) and somatic hypermutation of the antibody genes but also mutates “off-target” genes, with oncogenic consequences. Understanding the mechanisms that render such loci susceptible to AID is therefore necessary. We identify the H3K79 histone methyltransferase DOT1L as a nuclear AID-proximal factor required for CSR and AID off-target activity, including IgH-cMyc translocations. Mechanistically, DOT1L limits promoter-proximal transcriptional pause release. DOT1L inactivation reduced promoter-proximal paused RNA polymerase II (RNAPII) occupancy, while concomitantly increasing RNAPII Serine 2 phosphorylation and reducing cohesin at gene bodies. These changes were proportional to the amount of H3K79me3 lost and perturbed transcription elongation, as evidenced by downregulation of highly expressed long genes but upregulation of shorter primed genes. Thus, DOT1L restricting promoter-proximal pause release can explain the hitherto puzzling predominance of gene upregulation in DOT1L-deficient mammalian cells and establishes regulated pause release as a critical step for AID activity.
- 21 June 2023
- Published by Springer Nature in Research Square
Open AccessDOT1L limits RNAPII promoter-proximal pause release thus enabling Activation Induced Deaminase activity genome-wide
Activation induced deaminase (AID) initiates class switch recombination (CSR) and somatic hypermutation of the antibody genes but also mutates “off-target” genes, with oncogenic consequences. Understanding the mechanisms that render such loci susceptible to AID is therefore necessary. We identify the H3K79 histone methyltransferase DOT1L as a nuclear AID-proximal factor required for CSR and AID off-target activity, including IgH-cMyc translocations. Mechanistically, DOT1L limits promoter-proximal transcriptional pause release. DOT1L inactivation reduced promoter-proximal paused RNA polymerase II (RNAPII) occupancy, while concomitantly increasing RNAPII Serine 2 phosphorylation and reducing cohesin at gene bodies. These changes were proportional to the amount of H3K79me3 lost and perturbed transcription elongation, as evidenced by downregulation of highly expressed long genes but upregulation of shorter primed genes. Thus, DOT1L restricting promoter-proximal pause release can explain the hitherto puzzling predominance of gene upregulation in DOT1L-deficient mammalian cells and establishes regulated pause release as a critical step for AID activity.
- 10 November 2021
- Published by Springer Nature in EMBO Reports
- Vol. 23 (1) , e51041
POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 10 November 2021
- Published by Springer Nature in EMBO Reports
- Vol. 23 (1) , e51041
POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 17 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-20
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
Aberrant expression of receptor tyrosine kinase AXL is linked to metastasis. AXL can be activated by its ligand GAS6 or by other kinases, but the signaling pathways conferring its metastatic activity are unknown. Here, we define the AXL-regulated phosphoproteome in breast cancer cells. We reveal that AXL stimulates the phosphorylation of a network of focal adhesion (FA) proteins, culminating in faster FA disassembly. Mechanistically, AXL phosphorylates NEDD9, leading to its binding to CRKII which in turn associates with and orchestrates the phosphorylation of the pseudo-kinase PEAK1. We find that PEAK1 is in complex with the tyrosine kinase CSK to mediate the phosphorylation of PAXILLIN. Uncoupling of PEAK1 from AXL signaling decreases metastasis in vivo, but not tumor growth. Our results uncover a contribution of AXL signaling to FA dynamics, reveal a long sought-after mechanism underlying AXL metastatic activity, and identify PEAK1 as a therapeutic target in AXL positive tumors.
- 17 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-20
Open AccessAXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
Aberrant expression of receptor tyrosine kinase AXL is linked to metastasis. AXL can be activated by its ligand GAS6 or by other kinases, but the signaling pathways conferring its metastatic activity are unknown. Here, we define the AXL-regulated phosphoproteome in breast cancer cells. We reveal that AXL stimulates the phosphorylation of a network of focal adhesion (FA) proteins, culminating in faster FA disassembly. Mechanistically, AXL phosphorylates NEDD9, leading to its binding to CRKII which in turn associates with and orchestrates the phosphorylation of the pseudo-kinase PEAK1. We find that PEAK1 is in complex with the tyrosine kinase CSK to mediate the phosphorylation of PAXILLIN. Uncoupling of PEAK1 from AXL signaling decreases metastasis in vivo, but not tumor growth. Our results uncover a contribution of AXL signaling to FA dynamics, reveal a long sought-after mechanism underlying AXL metastatic activity, and identify PEAK1 as a therapeutic target in AXL positive tumors.
- Open Access
- 10 February 2020
- Published by Springer Nature in Nature Cell Biology
- Vol. 22 (3) , 353
Author Correction: Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 10 February 2020
- Published by Springer Nature in Nature Cell Biology
- Vol. 22 (3) , 353
Open AccessAuthor Correction: Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- 23 December 2019
- Published by Springer Nature in Nature Cell Biology
- Vol. 22 (1) , 120-134
Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
Guanine nucleotide exchange factors (RhoGEFs) and GTPase-activating proteins (RhoGAPs) coordinate the activation state of the Rho family of GTPases for binding to effectors. Here, we exploited proximity-dependent biotinylation to systematically define the Rho family proximity interaction network from 28 baits to produce 9,939 high-confidence proximity interactions in two cell lines. Exploiting the nucleotide states of Rho GTPases, we revealed the landscape of interactions with RhoGEFs and RhoGAPs. We systematically defined effectors of Rho proteins to reveal candidates for classical and atypical Rho proteins. We used optogenetics to demonstrate that KIAA0355 (termed GARRE here) is a RAC1 interactor. A functional screen of RHOG candidate effectors identified PLEKHG3 as a promoter of Rac-mediated membrane ruffling downstream of RHOG. We identified that active RHOA binds the kinase SLK in Drosophila and mammalian cells to promote Ezrin–Radixin–Moesin phosphorylation. Our proximity interactions data pave the way for dissecting additional Rho signalling pathways, and the approaches described here are applicable to the Ras family.
- 23 December 2019
- Published by Springer Nature in Nature Cell Biology
- Vol. 22 (1) , 120-134
Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms
Guanine nucleotide exchange factors (RhoGEFs) and GTPase-activating proteins (RhoGAPs) coordinate the activation state of the Rho family of GTPases for binding to effectors. Here, we exploited proximity-dependent biotinylation to systematically define the Rho family proximity interaction network from 28 baits to produce 9,939 high-confidence proximity interactions in two cell lines. Exploiting the nucleotide states of Rho GTPases, we revealed the landscape of interactions with RhoGEFs and RhoGAPs. We systematically defined effectors of Rho proteins to reveal candidates for classical and atypical Rho proteins. We used optogenetics to demonstrate that KIAA0355 (termed GARRE here) is a RAC1 interactor. A functional screen of RHOG candidate effectors identified PLEKHG3 as a promoter of Rac-mediated membrane ruffling downstream of RHOG. We identified that active RHOA binds the kinase SLK in Drosophila and mammalian cells to promote Ezrin–Radixin–Moesin phosphorylation. Our proximity interactions data pave the way for dissecting additional Rho signalling pathways, and the approaches described here are applicable to the Ras family.
- Open Access
- 16 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-19
The endosomal sorting adaptor HD-PTP is required for ephrin-B:EphB signalling in cellular collapse and spinal motor axon guidance
The signalling output of many transmembrane receptors that mediate cell-cell communication is restricted by the endosomal sorting complex required for transport (ESCRT), but the impact of this machinery on Eph tyrosine kinase receptor function is unknown. We identified the ESCRT-associated adaptor protein HD-PTP as part of an EphB2 proximity-dependent biotin identification (BioID) interactome, and confirmed this association using co-immunoprecipitation. HD-PTP loss attenuates the ephrin-B2:EphB2 signalling-induced collapse of cultured cells and axonal growth cones, and results in aberrant guidance of chick spinal motor neuron axons in vivo. HD-PTP depletion abrogates ephrin-B2-induced EphB2 clustering, and EphB2 and Src family kinase activation. HD-PTP loss also accelerates ligand-induced EphB2 degradation, contrasting the effects of HD-PTP loss on the relay of signals from other cell surface receptors. Our results link Eph function to the ESCRT machinery and demonstrate a role for HD-PTP in the earliest steps of ephrin-B:EphB signalling, as well as in obstructing premature receptor depletion.
- 16 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-19
Open AccessThe endosomal sorting adaptor HD-PTP is required for ephrin-B:EphB signalling in cellular collapse and spinal motor axon guidance
The signalling output of many transmembrane receptors that mediate cell-cell communication is restricted by the endosomal sorting complex required for transport (ESCRT), but the impact of this machinery on Eph tyrosine kinase receptor function is unknown. We identified the ESCRT-associated adaptor protein HD-PTP as part of an EphB2 proximity-dependent biotin identification (BioID) interactome, and confirmed this association using co-immunoprecipitation. HD-PTP loss attenuates the ephrin-B2:EphB2 signalling-induced collapse of cultured cells and axonal growth cones, and results in aberrant guidance of chick spinal motor neuron axons in vivo. HD-PTP depletion abrogates ephrin-B2-induced EphB2 clustering, and EphB2 and Src family kinase activation. HD-PTP loss also accelerates ligand-induced EphB2 degradation, contrasting the effects of HD-PTP loss on the relay of signals from other cell surface receptors. Our results link Eph function to the ESCRT machinery and demonstrate a role for HD-PTP in the earliest steps of ephrin-B:EphB signalling, as well as in obstructing premature receptor depletion.
- Open Access
- 20 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-16
Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes
Gfi1b is a transcriptional repressor expressed in hematopoietic stem cells (HSCs) and megakaryocytes (MKs). Gfi1b deficiency leads to expansion of both cell types and abrogates the ability of MKs to respond to integrin. Here we show that Gfi1b forms complexes with β-catenin, its co-factors Pontin52, CHD8, TLE3 and CtBP1 and regulates Wnt/β-catenin-dependent gene expression. In reporter assays, Gfi1b can activate TCF-dependent transcription and Wnt3a treatment enhances this activation. This requires interaction between Gfi1b and LSD1 and suggests that a tripartite β-catenin/Gfi1b/LSD1 complex exists, which regulates Wnt/β-catenin target genes. Consistently, numerous canonical Wnt/β-catenin target genes, co-occupied by Gfi1b, β-catenin and LSD1, have their expression deregulated in Gfi1b-deficient cells. When Gfi1b-deficient cells are treated with Wnt3a, their normal cellularity is restored and Gfi1b-deficient MKs regained their ability to spread on integrin substrates. This indicates that Gfi1b controls both the cellularity and functional integrity of HSCs and MKs by regulating Wnt/β-catenin signaling pathway.
- 20 March 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-16
Open AccessGfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes
Gfi1b is a transcriptional repressor expressed in hematopoietic stem cells (HSCs) and megakaryocytes (MKs). Gfi1b deficiency leads to expansion of both cell types and abrogates the ability of MKs to respond to integrin. Here we show that Gfi1b forms complexes with β-catenin, its co-factors Pontin52, CHD8, TLE3 and CtBP1 and regulates Wnt/β-catenin-dependent gene expression. In reporter assays, Gfi1b can activate TCF-dependent transcription and Wnt3a treatment enhances this activation. This requires interaction between Gfi1b and LSD1 and suggests that a tripartite β-catenin/Gfi1b/LSD1 complex exists, which regulates Wnt/β-catenin target genes. Consistently, numerous canonical Wnt/β-catenin target genes, co-occupied by Gfi1b, β-catenin and LSD1, have their expression deregulated in Gfi1b-deficient cells. When Gfi1b-deficient cells are treated with Wnt3a, their normal cellularity is restored and Gfi1b-deficient MKs regained their ability to spread on integrin substrates. This indicates that Gfi1b controls both the cellularity and functional integrity of HSCs and MKs by regulating Wnt/β-catenin signaling pathway.